Should we treat high LDL cholesterol in ‘healthy’ elderly individuals?

Europe is an increasingly elderly society. In 2019, 14% of individuals in the European Union member countries were aged 65-79 years and about 6% were aged 80 years or more; over the next 20 years, the proportion aged at least 80 years is anticipated to more than double1. This is highly relevant in the context of prevention strategies aimed at reducing the burden of atherosclerotic cardiovascular disease (ASCVD).
Source: Atherosclerosis - Category: Cardiology Authors: Source Type: research